Dec 18, 2020 Low dose CBD medications to be available without prescription in Australia By Greg Bodulovic On 15 December 2020, the Australian Therapeutic Goods Administration (TGA) published its decision to down-schedule certain low dose...
Dec 14, 2020 Passage of the MORE Act Signals Positive Step Towards Commercial Federal Cannabis Legalization By Kelsey Tavaras Stefanie Fogel On December 4, 2020, the United States House of Representatives passed the Marijuana Opportunity Reinvestment and Expungement Act of 2020...
Dec 08, 2020 What’s the plan? A New Pharmaceutical Strategy for Europe By Darach Connolly Dr Kokularajah Paheenthararajah Mariana Ricardo On 25 November 2020, the European Commission published its Pharmaceutical Strategy for Europe (Strategy). The Strategy is relevant for...
Dec 03, 2020 Subsidised telehealth services to be become permanently available in Australia By Greg Bodulovic On 27 November 2020, the Australian Minister for Health announced an intention to make universal, whole-of-population telehealth services...
Nov 25, 2020 CBD product liability issues – taking proactive steps to mitigate risk By David Jaroslaw As the legal landscape for hemp continues to evolve, manufacturers and sellers of CBD products face increased challenges, such as an...
Nov 23, 2020 Telehealth around the world: A global guide By Greg Bodulovic Marco de Morpurgo The COVID-19 pandemic has caused healthcare systems around the globe to rapidly, and in some cases, radically rethink the delivery of...
Nov 20, 2020 Kanavape: a victory for CBD producers across Europe By Rahool Sarjua The Court of Justice of the European Union (CJEU) has ruled that EU Member States cannot prohibit the marketing of cannabidiol (CBD)...
Nov 11, 2020 New Zealand referendum for the legalisation of recreational cannabis fails By Emma Moran Sam Wilson By a slim majority of 50.7% to 48.4%, New Zealanders have voted against the legalisation of recreational cannabis following the...
Nov 06, 2020 The US Hemp Production Handbook By Stefanie Fogel Jae Kim Christopher Gismondi Hemp production in the US has soared in the last five years and is expected to continue its high rate of production and growth in the...
Nov 06, 2020 CBD as a novel food: the UK's stance post-Brexit By Rahool Sarjua The UK FSA's announcements that it will consider novel food applications for CBD products stands in contrast to the position taken by the...
Oct 27, 2020 Simplification and shortening of the public procurement timescale - will it really lift the Italian economy? By Roberta Moffa Giorgia Romitelli
Oct 26, 2020 Aspen: Quick Fix But Missed Opportunity By Bertold Bar-Bouyssiere Alina Lacatus Darach Connolly Jacob Borum +1 more... Show less What are commitments? The recent effort by the Commission to settle the Aspen case suggests that commitment decisions are the preferred...
Oct 23, 2020 Digital Therapeutics - evolution and entry into mainstream healthcare By Dr Kokularajah Paheenthararajah This international report on "Digital Therapeutics - Evolution and entry into mainstream healthcare" was recently published jointly by...
Oct 21, 2020 China signs off on PRC Biosecurity Law: What this means for industry players in China? By Ting Xiao William Fisher Horace Lam On 17 October 2020, the Standing Committee of the PRC National People’s Congress (“NPC”) passed the PRC Biosecurity Law, which will...
Oct 12, 2020 CANNABIS IN THAILAND: A DLA PIPER REVIEW By Pattama Jarupunphol Nahsinee Luengrattanakorn Jia Xiang On 19 February 2019, the Narcotics Act (No. 7) B.E. 2562 (2019) came into force ("Narcotics Act"). This decriminalised the use of...
Sep 23, 2020 FCA publishes guidance on its approach to cannabis-related companies looking to list in the UK By Dylan Kennett On 18 September the published guidance on the listing of cannabis-based businesses onto public stock exchanges in the UK. We consider the...